A study of the epidemiology of an endemic strain of staphylococcus haemolyticus (TOR-35) in a neonatal intensive care unit

Scandinavian Journal of Infectious Diseases
P KazembeD E Low


Coagulase-negative staphylococci (CNS) are among the most prevalent microorganisms that colonize and cause sepsis in neonatal intensive care units (NICU). We had previously identified a strain of CNS, Staphylococcus haemolyticus (TOR-35), in the NICU at Mount Sinai Hospital, that had been repeatedly isolated from blood cultures from neonates. We therefore carried out a prospective study to determine the frequency and time of colonization and the frequency of bacteremia in neonates over a 3.5 month period. This was accomplished by obtaining surface swabs within 1 h of birth and on days 3, 5, and 7 and by characterizing all blood culture isolates of CNS. We also determined what percentage of neonatal CNS bacteremias were due to this strain, between January 1, 1987 and December 31, 1990, by retrieving and typing all stock cultures of CNS from that period. All isolates were typed by species identification and antimicrobial susceptibility profile code. There were 76 (38%) neonates that became colonized with the TOR-35 strain at some time during their NICU stay. Lower birth weight was associated with colonization (p < 0.001), as was lower gestational age (p < 0.001). Only 1 neonate had a positive blood culture isolate for the TOR-35 ...Continue Reading


Feb 1, 1979·American Journal of Epidemiology·D K CzarlinskyD J Harris
Jul 1, 1992·Infection and Immunity·C BunceN Barg
Jan 1, 1990·Diagnostic Microbiology and Infectious Disease·S L HallR T Hall
Jun 1, 1990·Journal of Medical Microbiology·J EtienneJ Fleurette
Jun 1, 1990·American Journal of Infection Control·D A Goldmann
Jan 1, 1990·Journal of Clinical Microbiology·A McGeerA E Simor
Nov 1, 1987·The Pediatric Infectious Disease Journal·B K SchmidtE L Ford-Jones
Nov 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M SkulnickD E Low
May 1, 1989·The Journal of Infectious Diseases·D E LowM Lautatzis
Jun 1, 1989·The Journal of Pediatrics·C T D'AngioM C Harris
Apr 1, 1989·Antimicrobial Agents and Chemotherapy·J W FroggattG L Archer
Mar 1, 1986·The Journal of Hospital Infection·S Ponce de LeonR P Wenzel
Nov 1, 1987·The Pediatric Infectious Disease Journal·W M DunneM J Chusid
Jul 1, 1986·Journal of Clinical Microbiology·J T ParisiJ A Khan
Aug 1, 1983·Journal of Clinical Microbiology·G D ChristensenE H Beachey
May 1, 1980·The Journal of Infectious Diseases·J T Parisi, D W Hecht
Mar 1, 1982·Journal of Clinical Microbiology·R H EngD Armstrong
Jan 1, 1982·Annals of Internal Medicine·G D ChristensenR W Luther

❮ Previous
Next ❯


Jun 22, 2002·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Maria BjörkqvistJens Schollin
Sep 25, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G D de SilvaS J Peacock
Nov 2, 2013·Diagnostic Microbiology and Infectious Disease·Paula Marcele Afonso PereiraJosé Augusto Adler Pereira
Jun 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Gerda T. NoordhoekJohn E. Degener
May 4, 2004·The Lancet Infectious Diseases·Silvia F CostaElias J Anaissie
Mar 4, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T M PerlL A Herwaldt

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.